Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3733)
All Articles published online
|
Jun 1, 2004 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ma XT, Wang S, Ye YJ, Du RY, Cui ZR, Somsouk M. Constitutive activation of Stat3 signaling pathway in human colorectal carcinoma. World J Gastroenterol 2004; 10(11): 1569-1573 [PMID: 15162527 DOI: 10.3748/wjg.v10.i11.1569] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i11/1569.htm |
| Number | Citing Articles |
| 1 |
Alfred P. See, James E. Han, Jillian Phallen, Zev Binder, Gary Gallia, Fan Pan, Dilini Jinasena, Christopher Jackson, Zineb Belcaid, Sung Jin Jeong, Chelsea Gottschalk, Jing Zeng, Jacob Ruzevick, Sarah Nicholas, Young Kim, Emilia Albesiano, Drew M. Pardoll, Michael Lim. The role of STAT3 activation in modulating the immune microenvironment of GBM. Journal of Neuro-Oncology 2012; 110(3): 359 doi: 10.1007/s11060-012-0981-6
|
| 2 |
Jing Li, You‑Yu Liu, Xue‑Feng Yang, Dao‑Fu Shen, Hong‑Zhi Sun, Ke‑Qiang Huang, Hua‑Chuan Zheng. Effects and mechanism of STAT3 silencing on the growth and apoptosis of colorectal cancer cells. Oncology Letters 2018; doi: 10.3892/ol.2018.9368
|
| 3 |
Ujjal Das, Sushobhan Biswas, Sreya Chattopadhyay, Anindita Chakraborty, Rakhi Dey Sharma, Asoke Banerji, Sanjit Dey. Radiosensitizing effect of ellagic acid on growth of Hepatocellular carcinoma cells: an in vitro study. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-14211-4
|
| 4 |
Snehali Majumder, Uday Nagesh Shivaji, Rangarajan Kasturi, Alben Sigamani, Subrata Ghosh, Marietta Iacucci. Inflammatory bowel disease-related colorectal cancer: Past, present and future perspectives. World Journal of Gastrointestinal Oncology 2022; 14(3): 547-567 doi: 10.4251/wjgo.v14.i3.547
|
| 5 |
Nikola Gligorijević, Zorana Dobrijević, Miloš Šunderić, Dragana Robajac, Danilo Četić, Ana Penezić, Goran Miljuš, Olgica Nedić. The Insulin-like Growth Factor System and Colorectal Cancer. Life 2022; 12(8): 1274 doi: 10.3390/life12081274
|
| 6 |
Roozbeh Dehghannasiri, Byung-Jun Yoon, Edward R Dougherty. Efficient experimental design for uncertainty reduction in gene regulatory networks. BMC Bioinformatics 2015; 16(S13) doi: 10.1186/1471-2105-16-S13-S2
|
| 7 |
Saisai Wang, Yong Shen, Runfeng Qiu, Zhiliang Chen, Zhehang Chen, Wenbin Chen. 18 β-glycyrrhetinic acid exhibits potent antitumor effects against colorectal cancer via inhibition of cell proliferation and migration. International Journal of Oncology 2017; 51(2): 615 doi: 10.3892/ijo.2017.4059
|
| 8 |
Huiping Zhou, Yang Sun, Hongnan Zheng, Lei Fan, Qibing Mei, Yuan Tang, Xiaoqun Duan, Yuhua Li. Paris saponin VII extracted from trillium tschonoskii suppresses proliferation and induces apoptosis of human colorectal cancer cells. Journal of Ethnopharmacology 2019; 239: 111903 doi: 10.1016/j.jep.2019.111903
|
| 9 |
Junjie Zhao, Jarod Zepp, Katarzyna Bulek, Xiaoxia Li. SIGIRR, a negative regulator of colon tumorigenesis. Drug Discovery Today: Disease Mechanisms 2011; 8(3-4): e63 doi: 10.1016/j.ddmec.2012.02.003
|
| 10 |
Lianghui Zhi, Lianmei Zhao, Xue Zhang, Wei Liu, Bo Gao, Feifei Wang, Xiaoran Wang, Guiying Wang. SLCO1B3 promotes colorectal cancer tumorigenesis and metastasis through STAT3. Aging 2021; 13(18): 22164 doi: 10.18632/aging.203502
|
| 11 |
Bharat B Aggarwal, Prashasnika Gehlot. Inflammation and cancer: how friendly is the relationship for cancer patients?. Current Opinion in Pharmacology 2009; 9(4): 351 doi: 10.1016/j.coph.2009.06.020
|
| 12 |
XIRUI WANG, LEI CAO, YINGYI WANG, XIEFENG WANG, NING LIU, YONGPING YOU. Regulation of let-7 and its target oncogenes (Review). Oncology Letters 2012; 3(5): 955 doi: 10.3892/ol.2012.609
|
| 13 |
Sahdeo Prasad, Vivek R. Yadav, Bokyung Sung, Simone Reuter, Ramaswamy Kannappan, Amit Deorukhkar, Parmeswaran Diagaradjane, Caimiao Wei, Veerabhadran Baladandayuthapani, Sunil Krishnan, Sushovan Guha, Bharat B. Aggarwal. Ursolic Acid Inhibits Growth and Metastasis of Human Colorectal Cancer in an Orthotopic Nude Mouse Model by Targeting Multiple Cell Signaling Pathways: Chemosensitization with Capecitabine. Clinical Cancer Research 2012; 18(18): 4942 doi: 10.1158/1078-0432.CCR-11-2805
|
| 14 |
Ben Zhao, Lu Wang, Hong Qiu, Mingsheng Zhang, Li Sun, Ping Peng, Qianqian Yu, Xianglin Yuan. Mechanisms of resistance to anti-EGFR therapy in colorectal cancer. Oncotarget 2017; 8(3): 3980 doi: 10.18632/oncotarget.14012
|
| 15 |
N.G. Shah, T.I. Trivedi, R.A. Tankshali, J.A. Goswami, D.H. Jetly, T.P. Kobawala, S.N. Shukla, P.M. Shah, R.J. Verma. Stat3 Expression in Oral Squamous Cell Carcinoma: Association with Clinicopathological Parameters and Survival. The International Journal of Biological Markers 2006; 21(3): 175 doi: 10.1177/172460080602100307
|
| 16 |
Hua Xiong, Zhi-Gang Zhang, Xiao-Qing Tian, Dan-Feng Sun, Qin-Chuan Liang, Yan-Jie Zhang, Rong Lu, Ying-Xuan Chen, Jing-Yuan Fang. Inhibition of JAK1, 2/STAT3 Signaling Induces Apoptosis, Cell Cycle Arrest, and Reduces Tumor Cell Invasion in Colorectal Cancer Cells. Neoplasia 2008; 10(3): 287 doi: 10.1593/neo.07971
|
| 17 |
Wan-Li Cheng, Po-Hao Feng, Kang-Yun Lee, Kuan-Yuan Chen, Wei-Lun Sun, Nguyen Van Hiep, Ching-Shan Luo, Sheng-Ming Wu. The Role of EREG/EGFR Pathway in Tumor Progression. International Journal of Molecular Sciences 2021; 22(23): 12828 doi: 10.3390/ijms222312828
|
| 18 |
Azhar Rasul, Muhammad Khan, Muhammad Ali, Jiang Li, Xiaomeng Li, M. W. Jann, N. Simola. Targeting Apoptosis Pathways in Cancer with Alantolactone and Isoalantolactone. The Scientific World Journal 2013; 2013(1) doi: 10.1155/2013/248532
|
| 19 |
Chiara Rosso, Luca Cabianca, Fabrizio M. Gili. Non-invasive markers to detect colorectal cancer in asymptomatic population. Minerva Biotecnologica 2019; 31(1) doi: 10.23736/S1120-4826.18.02493-X
|
| 20 |
Beata Pajak, Barbara Gajkowska, Arkadiusz Orzechowski. Molecular basis of parthenolide-dependent proapoptotic activity in cancer cells.. Folia Histochemica et Cytobiologica 2008; 46(2) doi: 10.2478/v10042-008-0019-2
|
| 21 |
Yinyin Wang, Sihan Liu, Guancheng Jiang, Wanli Zhai, Liu Yang, Mengdi Li, Zhijie Chang, Bingtao Zhu. NOK associates with c-Src and promotes c-Src-induced STAT3 activation and cell proliferation. Cellular Signalling 2020; 75: 109762 doi: 10.1016/j.cellsig.2020.109762
|
| 22 |
Jiesheng Rong, Rui Pu, Hongru Sun, Yupeng Liu, Tian Tian, Haoran Bi, Tingting Xia, Lei Zhang, Yuanyuan Zhang, Yashuang Zhao, Lin Zhu. Association between the methylation of CpG islands in JAK-STAT pathway-related genes and colorectal cancer. Gene 2023; 868: 147357 doi: 10.1016/j.gene.2023.147357
|
| 23 |
Tao Su, Jing-Xuan Bai, Ying-Jie Chen, Xin-Ning Wang, Xiu-Qiong Fu, Ting Li, Hui Guo, Pei-Li Zhu, Yue Wang, Zhi-Ling Yu. An Ethanolic Extract of Ampelopsis Radix Exerts Anti-colorectal Cancer Effects and Potently Inhibits STAT3 Signaling In Vitro. Frontiers in Pharmacology 2017; 8 doi: 10.3389/fphar.2017.00227
|
| 24 |
Zhe Liu, Huan Wang, Lingnan Guan, Siyi Chen, Maode Lai. A novel small molecular STAT3 inhibitor, 5Br-6b, induces apoptosis and inhibits migration in colorectal cancer cells. Anti-Cancer Drugs 2018; 29(5): 402 doi: 10.1097/CAD.0000000000000605
|
| 25 |
Rong Lu, Yong-guo Zhang, Jun Sun. STAT3 activation in infection and infection-associated cancer. Molecular and Cellular Endocrinology 2017; 451: 80 doi: 10.1016/j.mce.2017.02.023
|
| 26 |
Esmeralda C. Marginean, Joanna Gotfrit, Horia Marginean, Daniel W. Yokom, Justin J. Bateman, Manijeh Daneshmand, Shelly Sud, Allen M. Gown, Derek Jonker, Timothy Asmis, Rachel A. Goodwin. Phosphorylated transducer and activator of transcription-3 (pSTAT3) immunohistochemical expression in paired primary and metastatic colorectal cancer. Translational Oncology 2021; 14(2): 100996 doi: 10.1016/j.tranon.2020.100996
|
| 27 |
Hua Xiong, Zhao‐Fei Chen, Qin‐Chuan Liang, Wan Du, Hui‐Min Chen, Wen‐Yu Su, Guo‐Qiang Chen, Ze‐Guang Han, Jing‐Yuan Fang. Inhibition of DNA methyltransferase induces G2 cell cycle arrest and apoptosis in human colorectal cancer cells via inhibition of JAK2/STAT3/STAT5 signalling. Journal of Cellular and Molecular Medicine 2009; 13(9b): 3668 doi: 10.1111/j.1582-4934.2009.00661.x
|
| 28 |
Takashi Uchiyama, Hirokazu Takahashi, Hiroki Endo, Eiji Sakai, Kunihiro Hosono, Yoji Nagashima, Atsushi Nakajima. IL-6 Plays Crucial Roles in Sporadic Colorectal Cancer through the Cytokine Networks including CXCL7. Journal of Cancer Therapy 2012; 3(06): 874 doi: 10.4236/jct.2012.326112
|
| 29 |
Jill J. Ranger, David E. Levy, Solmaz Shahalizadeh, Michael Hallett, William J. Muller. Identification of a Stat3-Dependent Transcription Regulatory Network Involved in Metastatic Progression. Cancer Research 2009; 69(17): 6823 doi: 10.1158/0008-5472.CAN-09-1684
|
| 30 |
Naveena B. Janakiram, Altaf Mohammed, Taylor Bryant, Misty Brewer, Laura Biddick, Stan Lightfoot, Mark L. Lang, Chinthalapally V. Rao. Adoptive transfer of regulatory T cells promotes intestinal tumorigenesis and is associated with decreased NK cells and IL‐22 binding protein. Molecular Carcinogenesis 2015; 54(10): 986 doi: 10.1002/mc.22168
|
| 31 |
Sujatha Peela, Dariya Begum, Ganji Purnachandra Nagaraju. Novel therapeutic approaches for gastrointestinal malignancies. Diagnostics and Therapeutic Advances in GI Malignancies 2020; : 193 doi: 10.1007/978-981-15-5471-1_12
|
| 32 |
Li Lin, Aiguo Liu, Zhengang Peng, Huey-Jen Lin, Pui-Kai Li, Chenglong Li, Jiayuh Lin. STAT3 Is Necessary for Proliferation and Survival in Colon Cancer–Initiating Cells. Cancer Research 2011; 71(23): 7226 doi: 10.1158/0008-5472.CAN-10-4660
|
| 33 |
Chongqiang Zhao, Wenlong Wang, Wenying Yu, David Jou, Yina Wang, Haiyan Ma, Hui Xiao, Hua Qin, Cuntai Zhang, Jiagao Lü, Sheng Li, Chenglong Li, Jiayuh Lin, Li Lin. A novel small molecule STAT3 inhibitor, LY5, inhibits cell viability, colony formation, and migration of colon and liver cancer cells. Oncotarget 2016; 7(11): 12917 doi: 10.18632/oncotarget.7338
|
| 34 |
Ting-Hong Ye, Fang-Fang Yang, Yong-Xia Zhu, Ya-Li Li, Qian Lei, Xue-Jiao Song, Yong Xia, Ying Xiong, Li-Dan Zhang, Ning-Yu Wang, Li-Feng Zhao, Hong-Feng Gou, Yong-Mei Xie, Sheng-Yong Yang, Luo-Ting Yu, Li Yang, Yu-Quan Wei. Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis. Cell Death & Disease 2017; 8(1): e2534 doi: 10.1038/cddis.2016.452
|
| 35 |
Wanlu Li, Mi-Ra Lee, Taeyeong Kim, Young Wan Kim, Mee-Yon Cho. Activated STAT3 may participate in tumor progression through increasing CD133/survivin expression in early stage of colon cancer. Biochemical and Biophysical Research Communications 2018; 497(1): 354 doi: 10.1016/j.bbrc.2018.02.084
|
| 36 |
Jennifer Dien Bard, Pascal Gelebart, Mona Anand, Zoulika Zak, Samar A. Hegazy, Hesham M. Amin, Raymond Lai. IL-21 Contributes to JAK3/STAT3 Activation and Promotes Cell Growth in ALK-Positive Anaplastic Large Cell Lymphoma. The American Journal of Pathology 2009; 175(2): 825 doi: 10.2353/ajpath.2009.080982
|
| 37 |
Shin-Yi Chung, Yen-Hsi Chen, Pei-Rong Lin, Ta-Chung Chao, Jung-Chen Su, Chung-Wai Shiau, Yeu Su. Two novel SHP-1 agonists, SC-43 and SC-78, are more potent than regorafenib in suppressing the in vitro stemness of human colorectal cancer cells. Cell Death Discovery 2018; 4(1) doi: 10.1038/s41420-018-0084-z
|
| 38 |
Mia M. Wu, Z. Zhang, Christy W.S. Tong, ViVi W. Yan, William C.S. Cho, Kenneth K.W. To. Repurposing of niclosamide as a STAT3 inhibitor to enhance the anticancer effect of chemotherapeutic drugs in treating colorectal cancer. Life Sciences 2020; 262: 118522 doi: 10.1016/j.lfs.2020.118522
|
| 39 |
Debasish Basak, Mohammad Nasir Uddin, Jake Hancock. The Role of Oxidative Stress and Its Counteractive Utility in Colorectal Cancer (CRC). Cancers 2020; 12(11): 3336 doi: 10.3390/cancers12113336
|
| 40 |
Kun Ji, Mingxuan Zhang, Qi Chu, Yong Gan, Hui Ren, Liyan Zhang, Liwei Wang, Xiaoxiu Li, Wei Wang, Xianglin Shi. The Role of p-STAT3 as a Prognostic and Clinicopathological Marker in Colorectal Cancer: A Systematic Review and Meta-Analysis. PLOS ONE 2016; 11(8): e0160125 doi: 10.1371/journal.pone.0160125
|
| 41 |
Li Lin, David Jou, Yina Wang, Haiyan Ma, Tianshu Liu, James Fuchs, Pui-Kai Li, Jiagao Lü, Chenglong Li, Jiayuh Lin. STAT3 as a potential therapeutic target in ALDH+ and CD44+/CD24+ stem cell-like pancreatic cancer cells. International Journal of Oncology 2016; 49(6): 2265 doi: 10.3892/ijo.2016.3728
|
| 42 |
Hua Xiong, Wan Du, Tian‐Tian Sun, Yan‐Wei Lin, Ji‐Lin Wang, Jie Hong, Jing‐Yuan Fang. A positive feedback loop between STAT3 and cyclooxygenase‐2 gene may contribute to Helicobacter pylori‐associated human gastric tumorigenesis. International Journal of Cancer 2014; 134(9): 2030 doi: 10.1002/ijc.28539
|
| 43 |
Vittoria Stigliano, Lupe Sanchez-Mete, Aline Martayan, Marcello Anti. Early-onset colorectal cancer: A sporadic or inherited disease?. World Journal of Gastroenterology 2014; 20(35): 12420-12430 doi: 10.3748/wjg.v20.i35.12420
|
| 44 |
Shahab Uddin, Azhar R. Hussain, Omar S. Khan, Khawla S. Al-Kuraya. Role of dysregulated expression of leptin and leptin receptors in colorectal carcinogenesis. Tumor Biology 2014; 35(2): 871 doi: 10.1007/s13277-013-1166-4
|
| 45 |
Olorunseun O. Ogunwobi, Ian L. P. Beales. The anti-apoptotic and growth stimulatory actions of leptin in human colon cancer cells involves activation of JNK mitogen activated protein kinase, JAK2 and PI3 kinase/Akt. International Journal of Colorectal Disease 2007; 22(4): 401 doi: 10.1007/s00384-006-0181-y
|
| 46 |
JIN YING, MASAHIKO TSUJII, JUMPEI KONDO, YOSHITO HAYASHI, MOTOHIKO KATO, TOMOFUMI AKASAKA, TAKUTA INOUE, ERI SHIRAISHI, TAHAHIRO INOUE, SATOSHI HIYAMA, YOSHIKI TSUJII, AKIRA MAEKAWA, SHOICHIRO KAWAI, TETSUJI FUJINAGA, MAEKAWA ARAKI, SHINICHIRO SHINZAKI, KENJI WATABE, TSUTOMU NISHIDA, HIDEKI IIJIMA, TETSUO TAKEHARA. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells. International Journal of Oncology 2015; 46(4): 1551 doi: 10.3892/ijo.2015.2851
|
| 47 |
Naveena B Janakiram, Chinthalapally V Rao. Molecular markers and targets for colorectal cancer prevention. Acta Pharmacologica Sinica 2008; 29(1): 1 doi: 10.1111/j.1745-7254.2008.00742.x
|
| 48 |
Rivat Christine, Rodrigues Sylvie, Bruyneel Erik, Piétu Geneviève, Robert Amélie, Redeuilh Gérard, Bracke Marc, Gespach Christian, Attoub Samir. Implication of STAT3 Signaling in Human Colonic Cancer Cells during Intestinal Trefoil Factor 3 (TFF3) – and Vascular Endothelial Growth Factor–Mediated Cellular Invasion and Tumor Growth. Cancer Research 2005; 65(1): 195 doi: 10.1158/0008-5472.195.65.1
|
| 49 |
Noemí Eiró, Francisco J Vizoso. Inflammation and cancer. World Journal of Gastrointestinal Surgery 2012; 4(3): 62-72 doi: 10.4240/wjgs.v4.i3.62
|
| 50 |
Shujie Hou, Yong Weon Yi, Hyo Jin Kang, Li Zhang, Hee Jeong Kim, Yali Kong, Yong Liu, Kan Wang, Hye-Sik Kong, Scott Grindrod, Insoo Bae, Milton L. Brown. Novel Carbazole Inhibits Phospho-STAT3 through Induction of Protein–Tyrosine Phosphatase PTPN6. Journal of Medicinal Chemistry 2014; 57(15): 6342 doi: 10.1021/jm4018042
|
| 51 |
Silke Lassmann, Ingrid Schuster, Axel Walch, Heike Göbel, Uta Jütting, Frank Makowiec, Ulrich Hopt, Martin Werner. STAT3 mRNA and protein expression in colorectal cancer: effects on STAT3-inducible targets linked to cell survival and proliferation. Journal of Clinical Pathology 2007; 60(2): 173 doi: 10.1136/jcp.2005.035113
|
| 52 |
Qianyu Wang, Xiaofei Shen, Gang Chen, Junfeng Du. Drug Resistance in Colorectal Cancer: From Mechanism to Clinic. Cancers 2022; 14(12): 2928 doi: 10.3390/cancers14122928
|
| 53 |
|
| 54 |
Jean-Philippe Spano, Gerard Milano, Clivier Rixe, Remi Fagard. JAK/STAT signalling pathway in colorectal cancer: A new biological target with therapeutic implications. European Journal of Cancer 2006; 42(16): 2668 doi: 10.1016/j.ejca.2006.07.006
|
| 55 |
Lakshana Sreenivasan, Hui Wang, Shyong Quin Yap, Pascal Leclair, Anthony Tam, Chinten James Lim. Autocrine IL-6/STAT3 signaling aids development of acquired drug resistance in Group 3 medulloblastoma. Cell Death & Disease 2020; 11(12) doi: 10.1038/s41419-020-03241-y
|
| 56 |
Seung Woo Lee, Young Yong Ahn, Yon Soo Kim, Sang Beum Kang, Soon Woo Nam, Dong Soo Lee, Hyun Yong Jeong, Jin Man Kim. The Immunohistochemical Expression of STAT3, Bcl-xL, and MMP-2 Proteins in Colon Adenoma and Adenocarcinoma. Gut and Liver 2012; 6(1): 45 doi: 10.5009/gnl.2012.6.1.45
|
| 57 |
Mohamed M. Shareef, Maha M. Shamloula, Asem A. Elfert, Mohamed El-sawaf, Hanan H. Soliman. Expression of the signal transducer and activator of transcription factor 3 and Janus kinase 3 in colorectal carcinomas, colonic adenomas and ulcerative colitis. Arab Journal of Gastroenterology 2009; 10(1): 25 doi: 10.1016/j.ajg.2009.03.006
|
| 58 |
W.F. Qian, W.X. Guan, Y. Gao, J.F. Tan, Z.M. Qiao, H. Huang, C.L. Xia. Inhibition of STAT3 by RNA interference suppresses angiogenesis in colorectal carcinoma. Brazilian Journal of Medical and Biological Research 2011; 44(12): 1222 doi: 10.1590/S0100-879X2011007500143
|
| 59 |
Hua Xiong, Wan Du, Yan‐Jie Zhang, Jie Hong, Wen‐Yu Su, Jie‐Ting Tang, Ying‐Chao Wang, Rong Lu, Jing‐Yuan Fang. Trichostatin A, a histone deacetylase inhibitor, suppresses JAK2/STAT3 signaling via inducing the promoter‐associated histone acetylation of SOCS1 and SOCS3 in human colorectal cancer cells. Molecular Carcinogenesis 2012; 51(2): 174 doi: 10.1002/mc.20777
|
| 60 |
Yesol Bak, Taeho Kwon, In seon Bak, Jintae Hong, Dae-Yeul Yu, Do-Young Yoon. IL-32θ inhibits stemness and epithelial-mesenchymal transition of cancer stem cellsviathe STAT3 pathway in colon cancer. Oncotarget 2016; 7(6): 7307 doi: 10.18632/oncotarget.7007
|
| 61 |
Shengli Pan, Yingying Deng, Jun Fu, Yuhao Zhang, Zhijin Zhang, Xiaokun Ru, Xianju Qin. TRIM52 promotes colorectal cancer cell proliferation through the STAT3 signaling. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-0775-4
|
| 62 |
Ching‐Shu Lai, Mei‐Ling Tsai, An‐Chin Cheng, Shiming Li, Chih‐Yu Lo, Yu Wang, Hang Xiao, Chi‐Tang Ho, Ying‐Jan Wang, Min‐Hsiung Pan. Chemoprevention of colonic tumorigenesis by dietary hydroxylated polymethoxyflavones in azoxymethane‐treated mice. Molecular Nutrition & Food Research 2011; 55(2): 278 doi: 10.1002/mnfr.201000224
|
| 63 |
Rakesh Naidu, Lim Vin Nee, Mak Joon Wah, Kevin Moissinac, A. Rahman A. Jamal, Isa Mohd Rose, Yunus Gul Alif Gul, Patricia Lim Kim Chooi, Gregory Tan Jin San. Protein Expression of STAT3, pSTAT3, MMP-7 and VEGF in Colorectal Adenocarcinoma: An Immunohistochemical Study. Journal of Cancer Therapy 2014; 5(13): 1175 doi: 10.4236/jct.2014.513119
|
| 64 |
Chen Zhong, Guojuan Wang, Min Guo, Naicheng Zhu, Xiudan Chen, Yuwei Yan, Nanxin Li, Wenyan Yu. The Role of Tumor Stem Cells in Colorectal Cancer Drug Resistance. Cancer Control 2024; 31 doi: 10.1177/10732748241274196
|
| 65 |
Dora Colussi, Giovanni Brandi, Franco Bazzoli, Luigi Ricciardiello. Molecular Pathways Involved in Colorectal Cancer: Implications for Disease Behavior and Prevention. International Journal of Molecular Sciences 2013; 14(8): 16365 doi: 10.3390/ijms140816365
|
| 66 |
Jufeng Zhang, Xia Luo, Huiming Li, Ling Deng, Ying Wang. Genome-Wide Uncovering of STAT3-Mediated miRNA Expression Profiles in Colorectal Cancer Cell Lines. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/187105
|
| 67 |
Ewa Nowakowska-Zajdel, Urszula Mazurek, Malgorzata Stachowicz, Elzbieta Niedworok, Edyta Fatyga, Małgorzata Muc-Wierzgoń. Cellular Signal Transduction Pathways by Leptin in Colorectal Cancer Tissue: Preliminary Results. ISRN Endocrinology 2011; 2011: 1 doi: 10.5402/2011/575397
|
| 68 |
Joaquina Baranda, Stephen Williamson. The new paradigm in the treatment of colorectal cancer: are we hitting the right target?. Expert Opinion on Investigational Drugs 2007; 16(3): 311 doi: 10.1517/13543784.16.3.311
|
| 69 |
Jie Zheng, Mi Hee Park, Dong Ju Son, Min Gi Choi, Jeong Soon Choi, Kyung Tak Nam, Hae Deun Kim, Kevin Rodriguez, Benjamin Gann, Young Wan Ham, Sang Bae Han, Jin Tae Hong. (E)-4-(3-(3,5-dimethoxyphenyl)allyl)-2-methoxyphenol inhibits growth of colon tumors in mice. Oncotarget 2015; 6(39): 41929 doi: 10.18632/oncotarget.5861
|
| 70 |
Haseeb Ahsan, Moammir Hasan Aziz, Nihal Ahmad. Ultraviolet B exposure activates Stat3 signaling via phosphorylation at tyrosine705 in skin of SKH1 hairless mouse: A target for the management of skin cancer?. Biochemical and Biophysical Research Communications 2005; 333(1): 241 doi: 10.1016/j.bbrc.2005.05.106
|
| 71 |
Wei Shi, Dan Yan, Chongqiang Zhao, Miaomiao Xiao, Yina Wang, Haiyan Ma, Tianshu Liu, Hua Qin, Cuntai Zhang, Chenglong Li, Jiayuh Lin, Sheng Li, Jiagao Lv, Li Lin. Inhibition of IL-6/STAT3 signaling in human cancer cells using Evista. Biochemical and Biophysical Research Communications 2017; 491(1): 159 doi: 10.1016/j.bbrc.2017.07.067
|
| 72 |
Yun Tian, Ying Ye, Wei Gao, Hong Chen, Ting Song, Daqing Wang, Xiaoyun Mao, Changshan Ren. Aspirin promotes apoptosis in a murine model of colorectal cancer by mechanisms involving downregulation of IL-6–STAT3 signaling pathway. International Journal of Colorectal Disease 2011; 26(1): 13 doi: 10.1007/s00384-010-1060-0
|
| 73 |
Joanna Wawszczyk, Katarzyna Jesse, Sławomir Smolik, Małgorzata Kapral. Mechanism of Pterostilbene-Induced Cell Death in HT-29 Colon Cancer Cells. Molecules 2022; 27(2): 369 doi: 10.3390/molecules27020369
|
| 74 |
Fahima Danesh Pouya, Yousef Rasmi, Mohadeseh Nemati. Signaling Pathways Involved in 5-FU Drug Resistance in Cancer. Cancer Investigation 2022; 40(6): 516 doi: 10.1080/07357907.2022.2055050
|
| 75 |
Mikio Tomida, Hideki Ohtake, Takashi Yokota, Yasuhito Kobayashi, Masafumi Kurosumi. Stat3 up-regulates expression of nicotinamide N-methyltransferase in human cancer cells. Journal of Cancer Research and Clinical Oncology 2008; 134(5): 551 doi: 10.1007/s00432-007-0318-6
|
| 76 |
Li Lin, James Fuchs, Chenglong Li, Veronica Olson, Tanios Bekaii-Saab, Jiayuh Lin. STAT3 signaling pathway is necessary for cell survival and tumorsphere forming capacity in ALDH+/CD133+ stem cell-like human colon cancer cells. Biochemical and Biophysical Research Communications 2011; 416(3-4): 246 doi: 10.1016/j.bbrc.2011.10.112
|
| 77 |
Songhee Han, Ae Jin Jeong, Heejung Yang, Kyo Bin Kang, Haeri Lee, Eun Hee Yi, Byung-Hak Kim, Chung-Hyun Cho, Jin Woong Chung, Sang Hyun Sung, Sang-Kyu Ye. Ginsenoside 20(S)-Rh2 exerts anti-cancer activity through targeting IL-6-induced JAK2/STAT3 pathway in human colorectal cancer cells. Journal of Ethnopharmacology 2016; 194: 83 doi: 10.1016/j.jep.2016.08.039
|
| 78 |
Elisabeth Ziesché, Malte Bachmann, Hartmut Kleinert, Josef Pfeilschifter, Heiko Mühl. The Interleukin-22/STAT3 Pathway Potentiates Expression of Inducible Nitric-oxide Synthase in Human Colon Carcinoma Cells. Journal of Biological Chemistry 2007; 282(22): 16006 doi: 10.1074/jbc.M611040200
|
| 79 |
Franck Monnien, Harouna Zaki, Christophe Borg, Christiane Mougin, Jean-François Bosset, Mariette Mercier, Francine Arbez-Gindre, Bernadette Kantelip. Prognostic value of phosphorylated STAT3 in advanced rectal cancer: a study from 104 French patients included in the EORTC 22921 trial. Journal of Clinical Pathology 2010; 63(10): 873 doi: 10.1136/jcp.2010.076414
|
| 80 |
Chadrashekar Kagepura Thammaiah, Shankar Jayaram. Role of let-7 family microRNA in breast cancer. Non-coding RNA Research 2016; 1(1): 77 doi: 10.1016/j.ncrna.2016.10.003
|
| 81 |
Ian L.P. Beales, O. Ogunwobi. Glycine-extended gastrin inhibits apoptosis in colon cancer cells via separate activation of Akt and JNK pathways. Molecular and Cellular Endocrinology 2006; 247(1-2): 140 doi: 10.1016/j.mce.2005.12.050
|
| 82 |
Zhaoyan Lin, Qingqing Li, Ying Zhao, Zixiang Lin, Nan Cheng, Di Zhang, Gang Liu, Jiahao Lin, Hong Zhang, Degui Lin. Combination of Auranofin and ICG-001 Suppress the Proliferation and Metastasis of Colon Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.738085
|
| 83 |
Rathindranath Baral, Anamika Bose, Chinmoyee Ray, Sonali Paul, Smarajit Pal, Enamul Haque, Bhagawan Mishra, Debolina Pal, Jatin Kumar Nagpal, Chinmay Kumar Panda, Bibhu Ranjan Das. Association of early phase of colorectal carcinogenesis with STAT3 activation and its relevance in apoptosis regulation. Experimental and Molecular Pathology 2009; 87(1): 36 doi: 10.1016/j.yexmp.2009.03.002
|
| 84 |
Ujjal Das, Krishnendu Manna, Arghya Adhikary, Snehasis Mishra, Krishna Das Saha, Rakhi Dey Sharma, Biswanath Majumder, Sanjit Dey. Ferulic acid enhances the radiation sensitivity of lung and liver carcinoma cells by collapsing redox homeostasis: mechanistic involvement of Akt/p38 MAPK signalling pathway. Free Radical Research 2019; 53(9-10): 944 doi: 10.1080/10715762.2019.1655559
|
| 85 |
T Kusaba, T Nakayama, K Yamazumi, Y Yakata, A Yoshizaki, T Nagayasu, I Sekine. Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors. Journal of Clinical Pathology 2005; 58(8): 833 doi: 10.1136/jcp.2004.023416
|
| 86 |
Fangfang Yang, Tinghong Ye, Zhihao Liu, Aiping Fang, Yi Luo, Wei wei, Yujue Li, Yali Li, Anqi Zeng, Yuanle Deng, Hongfeng Gou, Yongmei Xie, Yiwen Zhang, Yuquan Wei. Niclosamide induces colorectal cancer apoptosis, impairs metastasis and reduces immunosuppressive cells in vivo. RSC Advances 2016; 6(107): 106019 doi: 10.1039/C6RA21533E
|
| 87 |
Wei Shi, Lintong Men, Xiu Pi, Tao Jiang, Dewei Peng, Shengqi Huo, Pengcheng Luo, Moran Wang, Junyi Guo, Yue Jiang, Lulu Peng, Li Lin, Sheng Li, Jiagao Lv. Shikonin suppresses colon cancer cell growth and exerts synergistic effects by regulating ADAM17 and the IL‑6/STAT3 signaling pathway. International Journal of Oncology 2021; 59(6) doi: 10.3892/ijo.2021.5279
|